{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:42:15Z","timestamp":1793018535828,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":5370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.jpainsymman.2005.01.007","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T03:50:48Z","timestamp":1118807448000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"special_numbering":"S","title":["Hydromorphone"],"prefix":"10.1016","volume":"29","author":[{"given":"Alison","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003447","article-title":"Hydromorphone for acute and chronic pain","author":"Quigley","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib2","series-title":"Report on cancer pain relief and palliative care","author":"World Health Organization","year":"1990"},{"issue":"2","key":"10.1016\/j.jpainsymman.2005.01.007_bib3","first-page":"84","article-title":"Hydromorphone: pharmacology and clinical applications in cancer patients","volume":"9","author":"Sarhill","year":"2001","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.jpainsymman.2005.01.007_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(94)90084-1","article-title":"Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists","volume":"59","author":"Sjogren","year":"1994","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.jpainsymman.2005.01.007_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0304-3959(93)90232-E","article-title":"Opioid hyperexcitability: the application of alternate opioid therapy","volume":"53","author":"MacDonald","year":"1993","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3959(96)03313-1","article-title":"Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations","volume":"70","author":"Manfredi","year":"1997","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jpainsymman.2005.01.007_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5694\/j.1326-5377.1999.tb126885.x","article-title":"Opioid substitution to reduce adverse effects in cancer pain management","volume":"170","author":"Ashby","year":"1999","journal-title":"Med J Aust"},{"issue":"9","key":"10.1016\/j.jpainsymman.2005.01.007_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJM199403033300926","article-title":"New clinical-practice guidelines for the management of pain in patients with cancer","volume":"330","author":"Jacox","year":"1994","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00000542-199212000-00008","article-title":"Morphine and hydromorphone epidural analgesia. A prospective, randomized comparison","volume":"77","author":"Chaplan","year":"1992","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1460-9592.1999.00370.x","article-title":"Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery","volume":"9","author":"Goodarzi","year":"1999","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib11","series-title":"Acute pain management: operative or medical procedures and trauma. Clinical practice guideline no. 1","author":"Carr","year":"1992"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib12","series-title":"Advances in pain research and therapy, vol. 8","first-page":"129","article-title":"Clinical analgesic studies of hydromorphone","author":"Houde","year":"1986"},{"issue":"3","key":"10.1016\/j.jpainsymman.2005.01.007_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0885-3924(94)00121-Z","article-title":"Hydromorphone metabolite accumulation in renal failure","volume":"10","author":"Babul","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib14","series-title":"The management of pain","first-page":"1640","article-title":"Systemic analgesics","author":"Benedetti","year":"1990"},{"issue":"4","key":"10.1016\/j.jpainsymman.2005.01.007_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/j.1552-4604.1981.tb05693.x","article-title":"Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects","volume":"21","author":"Vallner","year":"1981","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1552-4604.1995.tb04743.x","article-title":"Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone","volume":"35","author":"Hagen","year":"1995","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.1996.14.5.1713","article-title":"A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group","volume":"14","author":"Bruera","year":"1996","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib18","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y","article-title":"Comparative clinical efficacy and safety of immediate-release and controlled-release hydromorphone for chronic severe cancer pain","volume":"74","author":"Hays","year":"1994","journal-title":"Cancer"},{"issue":"8739","key":"10.1016\/j.jpainsymman.2005.01.007_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0140-6736(91)93401-T","article-title":"Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain","volume":"337","author":"Moulin","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3959(97)03336-8","article-title":"Hydromorphone analgesia after intravenous bolus administration","volume":"71","author":"Coda","year":"1997","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/104990910001700513","article-title":"Use of continuous ambulatory infusions of concentrated subcutaneous (s.q.) hydromorphone versus intravenous (i.v.) morphine: cost implications for palliative care","volume":"17","author":"Fudin","year":"2000","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0885-3924(89)90061-4","article-title":"Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer pain","volume":"4","author":"Adams","year":"1989","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.jpainsymman.2005.01.007_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0885-3924(93)90128-I","article-title":"Local tolerance to subcutaneous infusions of high concentrations of hydromorphone: a prospective study","volume":"8","author":"Bruera","year":"1993","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF03011773","article-title":"Epidural morphine vs hydromorphone in post-caesarean section patients","volume":"43","author":"Halpern","year":"1996","journal-title":"Can J Anaesth"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib25","first-page":"65","article-title":"Epidural hydromorphone for postcesarean analgesia","volume":"68","author":"Chestnut","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.jpainsymman.2005.01.007_bib26","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1213\/00000539-198712000-00026","article-title":"Experience with epidural hydromorphone for post-thoracotomy pain relief","volume":"66","author":"Shulman","year":"1987","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00000542-198706000-00021","article-title":"Epidural hydromorphone: a double-blind comparison with intramuscular hydromorphone for postcesarean section analgesia","volume":"66","author":"Henderson","year":"1987","journal-title":"Anesthesiology"},{"issue":"6554","key":"10.1016\/j.jpainsymman.2005.01.007_bib28","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/bmj.293.6554.1101","article-title":"Morphine intoxication in renal failure; the role of morphine-6-glucuronide","volume":"293","author":"Osborne","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"10.1016\/j.jpainsymman.2005.01.007_bib29","first-page":"344","article-title":"Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations","volume":"24","author":"Hasselstrom","year":"1993","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.jpainsymman.2005.01.007_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0885-3924(91)90961-3","article-title":"Chronic nausea and morphine-6-glucuronide","volume":"6","author":"Hagen","year":"1991","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/00498250110119090","article-title":"Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient","volume":"32","author":"Zheng","year":"2002","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0024-3205(98)00288-4","article-title":"Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation","volume":"63","author":"Wright","year":"1998","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.jpainsymman.2005.01.007_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0024-3205(01)01133-X","article-title":"Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide","volume":"69","author":"Wright","year":"2001","journal-title":"Life Sci"},{"issue":"7","key":"10.1016\/j.jpainsymman.2005.01.007_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1440-1681.2000.03290.x","article-title":"Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites","volume":"27","author":"Smith","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0885-3924(97)00001-8","article-title":"Strychnine-like multi-focal myoclonus and seizures from extremely high dose opioids: treatment strategies","volume":"14","author":"Hagen","year":"1997","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/082585979300900110","article-title":"Palliative care round: cognitive failure and coma after renal failure in a patient receiving captopril and hydromorphone","volume":"9","author":"Fainsinger","year":"1993","journal-title":"J Palliat Care"},{"issue":"7\u20138","key":"10.1016\/j.jpainsymman.2005.01.007_bib37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/028418698430151","article-title":"Recent developments in palliative cancer care","volume":"37","author":"Bruera","year":"1998","journal-title":"J Acta Oncol"},{"issue":"4","key":"10.1016\/j.jpainsymman.2005.01.007_bib38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T","article-title":"Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine","volume":"78","author":"Bruera","year":"1996","journal-title":"Cancer"},{"issue":"2\u20133","key":"10.1016\/j.jpainsymman.2005.01.007_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-3959(96)03213-7","article-title":"Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA","volume":"68","author":"Dunbar","year":"1996","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib40","first-page":"1043","article-title":"A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia","volume":"82","author":"Rapp","year":"1996","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib41","first-page":"45","article-title":"Pharmacological management of cancer pain","volume":"27","author":"Walsh","year":"2000","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0885-3924(99)00036-6","article-title":"Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial","volume":"18","author":"Miller","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib43","first-page":"1","article-title":"A randomized crossover comparison of controlled-release hydromorphone tablets with controlled-release morphine tablets in patients with cancer pain","volume":"2","author":"Moriarty","year":"1999","journal-title":"J Clin Res"},{"issue":"7","key":"10.1016\/j.jpainsymman.2005.01.007_bib44","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1428::AID-CNCR21>3.0.CO;2-0","article-title":"Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain","volume":"79","author":"Hagen","year":"1997","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0885-3924(02)00390-1","article-title":"Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain","volume":"23","author":"Palangio","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.jpainsymman.2005.01.007_bib46","first-page":"521","article-title":"Effects of controlled-released morphine on quality of life for cancer pain","volume":"16","author":"Ferrell","year":"1989","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib47","article-title":"Multiple dose pharmacokinetics of OROS and immediate release (IR) hydromorphone (HM) in healthy subjects","volume":"14","author":"Shah","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00000542-200210000-00013","article-title":"Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers","volume":"97","author":"Drover","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00000542-200101000-00014","article-title":"Pharmacodynamics of orally administered sustained-release hydromorphone in humans","volume":"94","author":"Angst","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib50","author":"Kremer","year":"2002","journal-title":"Executive Medical Director: Purdue Pharma"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib51","unstructured":"Woodson ME, Strambaugh JE, Lacouture, PG, et al. Assessment of once-a-day controlled-release hydromorphone (Palladone XL) with 7 days' treatment at stable doses. Poster presented at the Annual Meeting of the American College of Clinical Pharmacology; Kansas City, October 24\u201327, 1999."},{"issue":"2","key":"10.1016\/j.jpainsymman.2005.01.007_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJM198001103020221","article-title":"Addiction rare in patients treated with narcotics","volume":"302","author":"Porter","year":"1980","journal-title":"N Engl J Med"},{"issue":"1 Suppl","key":"10.1016\/j.jpainsymman.2005.01.007_bib53","first-page":"S46","article-title":"Chronic opioid therapy in nonmalignant pain","volume":"5","author":"Portenoy","year":"1990","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.jpainsymman.2005.01.007_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0304-3959(82)90016-1","article-title":"Management of pain during debridement: a survey of U.S. burn units","volume":"13","author":"Perry","year":"1982","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jpainsymman.2005.01.007_bib55","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1155\/1999\/352469","article-title":"Efficacy and abuse potential of opioid analgesics and the treatment of chronic noncancer pain","volume":"4","author":"Darke","year":"1999","journal-title":"Pain Res Manage"},{"issue":"13","key":"10.1016\/j.jpainsymman.2005.01.007_bib56","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jama.283.13.1710","article-title":"Trends in medical use and abuse of opioid analgesics","volume":"283","author":"Joranson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib57","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpainsymman.2004.01.003","article-title":"A reassessment of trends in the medial use and abuse of opioid analgesics and implications for diversion control: 1997\u20132002","volume":"28","author":"Gilson","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib58","first-page":"284","article-title":"Oral hydromorphone in trauma","volume":"18","author":"Goldberg","year":"1965","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib59","first-page":"175","article-title":"A placebo-controlled study of an oral solution of 5 and 10 mg of hydromorphone hydrochloride in postoperative pain","volume":"45","author":"Jain","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"3A","key":"10.1016\/j.jpainsymman.2005.01.007_bib60","doi-asserted-by":"crossref","first-page":"A235","DOI":"10.1097\/00000542-198509001-00235","article-title":"Effects of epinephrine on epidural fentanyl, sufentanil, and hydromorphone for postoperative pain","volume":"63","author":"Parker","year":"1985","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2005.01.007_bib61","first-page":"A63","article-title":"Patient controlled epidural analgesia with hydromorphone versus single dose epidural morphine for post-caesarian analgesia","volume":"45","author":"Swica","year":"1998","journal-title":"Can J Anaesth"},{"issue":"3","key":"10.1016\/j.jpainsymman.2005.01.007_bib62","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2106\/00004623-199173030-00013","article-title":"Spinal narcotics for postoperative analgesia in total joint arthroplasty. A prospective study","volume":"73","author":"Drakeford","year":"1991","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib63","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0022-3476(96)70156-7","article-title":"Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone","volume":"129","author":"Collins","year":"1996","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib64","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1213\/00000539-196211000-00017","article-title":"An evaluation of dihydromorphinone in treating postoperative pain","volume":"41","author":"Hanna","year":"1962","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib65","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00000542-197505000-00021","article-title":"Relative analgesic potencies of morphine and hydromorphone in postoperative pain","volume":"42","author":"Mahler","year":"1975","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.jpainsymman.2005.01.007_bib66","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF03009831","article-title":"Hydromorphone patient-controlled analgesia (PCA) after coronary artery bypass surgery","volume":"41","author":"Searle","year":"1994","journal-title":"Can J Anaesth"},{"issue":"1","key":"10.1016\/j.jpainsymman.2005.01.007_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(90)91102-O","article-title":"Clinical analgesic assay of repeated and single doses of heroin and hydromorphone","volume":"41","author":"Wallenstein","year":"1990","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1553-2712.1994.tb02549.x","article-title":"Comparison of hydromorphone and meperidine for ureteral colic","volume":"1","author":"Jasani","year":"1994","journal-title":"Acad Emerg Med"},{"issue":"5","key":"10.1016\/j.jpainsymman.2005.01.007_bib69","first-page":"4","article-title":"Dental evaluation of hydromorphone (Dilaudid) for oral and maxillo-facial surgery","volume":"87","author":"Nasits","year":"1969","journal-title":"Tex Dent J"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib70","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1213\/00000539-196811000-00005","article-title":"Postoperative analgesia with hydromorphone and meperidine: a double-blind comparison","volume":"47","author":"Deutsch","year":"1968","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib71","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004630-199811000-00010","article-title":"A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia","volume":"19","author":"Sharar","year":"1998","journal-title":"J Burn Care Rehabil"},{"issue":"6","key":"10.1016\/j.jpainsymman.2005.01.007_bib72","first-page":"1228","article-title":"Comparison of indomethacin and dihydromorphinone in acute biliary stone pain","volume":"36","author":"Uden","year":"1984","journal-title":"Curr Ther Res"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392405000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392405000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:55:21Z","timestamp":1760129721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392405000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0885392405000333"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.01.007","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydromorphone","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}